Top compounds associated with response to SLC25A17


Feature Type Standardized
Nominal ANOVA
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.11 0.002
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.003
mRNA rigosertib CTRPv2 pan-cancer AAC 0.098 0.003
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.091 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.19 0.004
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.092 0.004
mRNA FK866 CTRPv2 pan-cancer AAC 0.11 0.004
Download CSV